Intellia Therapeutics, Inc.
NTLAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Intellia Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 11 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Larson Financial Group LLC | 2026-03-31 | 292 | $3.74K | SEC filing |
| Amova Asset Management Americas, Inc. | 2026-03-31 | 1,973,061 | $25.3M | SEC filing |
| Ensign Peak Advisors, Inc | 2026-03-31 | 8,069 | $103K | SEC filing |
| Vestmark Advisory Solutions, Inc. | 2026-03-31 | 550,144 | $7.05M | SEC filing |
| Aventura Private Wealth, LLC | 2026-03-31 | 1,990 | $25.5K | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 120,356 | $1.54M | SEC filing |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 2026-03-31 | 9,760 | Not shown | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2026-03-31 | 94,186 | $1.21M | SEC filing |
| Casdin Capital, LLC | 2026-03-31 | 355,000 | $4.55M | SEC filing |
| BENJAMIN EDWARDS INC | 2026-03-31 | 82,563 | $1.06M | SEC filing |
| Monetary Solutions, Ltd | 2026-03-31 | 65 | $833 | SEC filing |
| HUNTINGTON NATIONAL BANK | 2026-03-31 | 357 | $4.58K | SEC filing |
| IvyRock Asset Management (HK) Ltd | 2026-03-31 | 19,830 | $254K | SEC filing |
| MassMutual Private Wealth & Trust, FSB | 2026-03-31 | 231 | $2.96K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 30,058 | $385K | SEC filing |
| Allworth Financial LP | 2026-03-31 | 3,592 | $46.1K | SEC filing |
| Keating Financial Advisory Services, Inc. | 2026-03-31 | 729 | $9.35K | SEC filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2026-03-31 | 1,973 | $25.3K | SEC filing |
| GRANDFIELD & DODD, LLC | 2026-03-31 | 48,430 | $621K | SEC filing |
| UBS Group AG | 2026-03-31 | 2,689,486 | $34.5M | SEC filing |
- Each value is checked against Intellia Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Intellia Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Intellia Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-05 · LEONARD JOHN M: Larger than 64 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-01-05 · BASTA JAMES: Larger than 59 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-01-05 · Lebwohl David: Larger than 60 of the 65 other insider sales of Common Stock on file. SEC filing
- 2025-12-11 · LEONARD JOHN M: Larger than all 65 other insider sales of Common Stock on file. SEC filing
- 2025-12-11 · LEONARD JOHN M: Larger than 63 of the 65 other insider sales of Common Stock on file. SEC filing
- 2025-01-03 · LEONARD JOHN M: Larger than 62 of the 65 other insider sales of Common Stock on file. SEC filing
- 2024-01-03 · LEONARD JOHN M: Larger than 61 of the 65 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-02 | BASTA JAMES · EVP, General Counsel | Common Stock | S — Open market or private sale | −1,211 | 13.78 | SEC filing |
| 2026-03-02 | Clark Eliana · EVP, Chief Technical Officer | Common Stock | S — Open market or private sale | −607 | 13.78 | SEC filing |
| 2026-01-05 | Cohen Fred E · Director | Common Stock | P — Open market or private purchase | +150,000 | 9.35 | SEC filing |
| 2026-01-05 | Lebwohl David · EVP, Chief Medical Officer | Common Stock | S — Open market or private sale | −11,903 | 9.21 | SEC filing |
| 2026-01-05 | BASTA JAMES · EVP, General Counsel | Common Stock | S — Open market or private sale | −10,397 | 9.21 | SEC filing |
| 2026-01-05 | Schultes Birgit C · EVP, Chief Scientific Officer | Common Stock | S — Open market or private sale | −8,508 | 9.21 | SEC filing |
| 2026-01-05 | Dube Michael P · VP, Chief Accounting Officer | Common Stock | S — Open market or private sale | −2,989 | 9.21 | SEC filing |
| 2026-01-05 | LEONARD JOHN M · President and CEO | Common Stock | S — Open market or private sale | −34,146 | 9.21 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-09 | Verwiel Frank · Director | Common Stock | A — Grant, award, or other acquisition | +9,200 | SEC filing |
| 2026-06-09 | CHASE WILLIAM J · Director | Common Stock | A — Grant, award, or other acquisition | +9,200 | SEC filing |
| 2026-06-09 | Keresty Georgia · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +13,300 | SEC filing |
| 2026-06-09 | Goff Brian · Director | Common Stock | A — Grant, award, or other acquisition | +9,200 | SEC filing |
| 2026-06-09 | GOODMAN JESSE · Director | Common Stock | A — Grant, award, or other acquisition | +9,200 | SEC filing |
| 2026-06-09 | Bhanji Muna · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +13,300 | SEC filing |
| 2026-06-09 | Keresty Georgia · Director | Common Stock | A — Grant, award, or other acquisition | +9,200 | SEC filing |
| 2026-06-09 | Verwiel Frank · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +13,300 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.